Skip to main content

Closed

PGEN: Precigen, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-37.0% / yr

Operating margin-297.2%

ROIC-79.2%

Financially safe

Stretched

Debt / equity4.86×

Interest coverage-13.9×

Current ratio4.82×

Precigen, Inc.

PGENNASDAQ Global Select·USD·Closed

Precigen, Inc.

PGENNASDAQ·USD·Closed

$6.27

+5.56%

$6.27

+$0.33 (5.56%)

52W Range

100thpctl

Volume

1.18×avg

Mkt Cap

2.24BUSD

P/E

-4.9TTM

Div Yield

–ann

52W Range

100thpctl

Volume

1.18×avg

Market Cap

2.24BUSD

P/E Ratio

-4.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings